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Summary
The development of autoimmune disease in theMRL/MpJ-Ipr inbred mouse strain depends upon
the maturation of a subset ofT lymphocytes thatmay cause sustained activation of immunological
effector cells such as B cells and macrophages. We tested the hypothesis that abnormal effector
cell activation reflects constitutive overexpression of a T cell cytokine. We found that a newly
defined T cell cytokine, Eta-1, is expressed at very high levels in T cells from MRLA mice but
not normal mouse strains and in a CD4 - 8 - 45R+ T cell clone. The Eta-1 gene encodes a
secreted protein that binds specifically to macrophages, possibly via a cell adhesion receptor, resulting
in alterations in the mobility and activation state of this cell type (Patarca, R ., G . J. Freeman,
R . P. Singh, et al . 1989 .J. Exp Med . 170:145 ; Singh, R . P., R. Patarca, J . Schwartz, P. Singh,
and H . Cantor. 1990.J . ExpMed . 171:1931) . In addition, recent studies have indicated that Eta-1
can enhance secretion of IgM and IgG by mixtures of macrophages and B cells (Patarca, R.,
M. A. Lampe, M . V Iregai, andH. Cantor, manuscript in preparation) . Dysregulation of Eta-1
expression begins at the onset of autoimmune disease and continues throughout the course of
this disorder. Maximal levels of Eta-1 expression and the development of severe autoimmune
disease reflect the combined contribution of the lpr gene and MRL background genes .
T he MRL/MpJ-lpr (MRL/1) inbred mouse strain spon-
taneously develops a systemic autoimmune disease with
histopathological features ofhuman SLE and rheumatoid ar-
thritis (1) . The development of this syndrome is associated
with abnormal expansion of a subset ofT cells that co-express
CD1(Thy-1), TCRa/Aand theB cell markerCD45R (B220
isoform of leukocyte common antigen) and lack both CD4
and CD8 surface antigens (CDI+CD45R+CD4-CD8-)
(2) . The developmental pathway of this subset of T cells,
termed double-negative (DN)t T cells, is poorly understood,
although recent studies suggest that it may arise relatively
late in ontogeny from CD4+ precursors (3) . Although the
development of autoimmune disease is heralded by the ap-
pearance oflarge numbers ofDN cells in peripheral lymphoid
tissues, there is little information on the potential contribu-
tion of these cells to the sustained activation ofimmunolog-
ical effector cells that may mediate the autoimmune process.
In the present studies we determined the level of cytokine
genes expressed by a clone ofDN T cells in vitro. We found
Abbreviations used in this paper. DN, double-negative ; Eta-1, early T
lymphocyte activation 1 .
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that these cells selectively and constitutively expressed high
levels of the recently defined T cell cytokine Eta-1 (for early
T lymphocyte activation 1) . This prompted an analysis of
the expression of this gene during the development of au-
toimmune disease in the MRL/l model . We found that ex-
pression ofthis cytokine is substantially increased at the onset
of the disease process and remains elevated throughout the
course of this disorder. The relative contributions of MRL
background genes and the lpr mutation to dysregulated ex-
pression of Eta-1 are defined, and the implications of these
findings are discussed in the context of our current under-
standing of the immunological activities of the eta-1 protein.
Materials and Methods
Mice.
￿
MRLA andMRL/MpJ+ (MRL/n) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME) and from Dr. C .
Reinisch (Tufts University School ofVeterinary Medicine, Boston,
MA) . Lymphoid tissues from C3H/HeJ-lpr (OH/1) and C57BL/6-
lpr (B6/1) mice were kindly provided byDr. H . C . Morse III (Na-
tional Institutes of Health, Bethesda, MD) . Age-matched C3H/HeJ
(C3H/n) and C57BL/6J (B6/n) inbred mouse strains were obtained
from The Jackson Laboratory.
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￿
Ar5 is a CD4' THl mu-
rine clone specific for arsonylated proteins (4) and Ar5v is a variant
ofthis clone first detected because ofits enhanced growth in vitro
(5) . Cell surface immunofluorescenceWas performed by flow cyto-
metric analysis using aFACS. Ar5 and Ar5v cells(>90% viability)
were incubated with either anti-CD1(antiThy-1, AMT13, 1:100),
anti-CD4 (1:25), anti-CD8 (1:100) (Becton Dickinson& Co ., Moun-
tain View, CA), or anti-CD45R (anti-B220, RA3-2C2/1, 1:20,
from American Type Culture Collection, Rockville, MD) mAbs
at 4°C for 40 min . Cells were then washed thrice with PBS and
incubated with FITC-conjugated goat anti-rat IgG [F(ab')2 heavy
and light chains, 1:300; Cappel Laboratories, Durham, NC) for
an additional 30 min before additional washing in PBS and analysis.
Slot Blot Analysis. Cellular RNA was extracted using the
guanidium isothiocyanate method with cesium chloride gradient
modification (6) . The amount of RNA in each sample was esti-
mated by determining its absorbance at 260 nm (OD2w) . 20-Wg
aliquots ofRNA from each cellular sample (unless otherwise indi-
cated) were blotted onto nitrocellulose filters using a Minifold II
slot blotter (Schleicher & Schuell, Inc ., Keene, NH) and hybrid-
ized to 12P-labeled cDNA corresponding to Eta-1 (a 1.6-kb HaeIII
fragment from pcD-Eta-1) (7), GAPDH (glyceraldehyde 3-phosphate
dehydrogenase, a housekeeping gene) (8), 11,2 (9), 11,3 (10), and
IFN- ,y (5) . Northern blot analysis showed that thecDNA probes
for Eta-1 and GAPDH hybridized to a single species ofRNA and
the levels of RNA quantitated by densitometric measurement of
Northern blots were equivalent to those obtainedby slot blot anal-
ysis . Quantitation was performed as described previously (7) and
detailed below. After preflashing, Kodak X-OMAT films were ex-
posed and the intensity of radioactivity ofthe autoradiograms was
quantitated using an Ultroscan II laser densitometer (LKB Instru-
ments, Inc., Gaithersburg, MD), adjusting exposure times so that
the intensity ofautoradiographic signals corresponded to the linear
range of densitometric detection . To ensure that comparisons of
Eta-1 RNA levels in different cellular samples were based upon the
same amount ofRNA in each sample, the area under the densito-
metric peak for Eta-1 for each cellular RNA sample was divided
by the area under the GAPDH densitometric peak for the same
cellularRNA sample. The ratios ofEta-1 RNA to GAPDH RNA
for each cellular sample are referred to as relative densitometric units
(RDU) .
Results
Expression ofEta-1 by aDNB220+ T Cell Clone .
￿
We ex-
amined aDNT cell clone that arose during the in vitro growth
of a CD4+ THl clone, Ar5 (4, 5) . The variant, termed
Ar5v, retained expression ofCD1 but expressed neither CD4
nor CD8 . In addition, the variant clone but not the parent
expressedCD45R according to immunofluorescence and thus
had acquired the typical surface phenotype ofDN cells (Fig.
1A) . Analysis ofcDNA libraries derived fromAr5 and Ar5v
also showed that the variant retained expression of the Ar5
TCRa//3 (not shown) .
We asked whether transition from the CD4+8-CD45R -
phenotype of Ar5 to the CD4 - 8 -CD45R' DN phenotype
ofAr5v was accompanied by a change in the expression of
genes encoding T cell cytokines. Resting Ar5 cells did not
express detectable levels of rytokine genes, including IL2,
11,3, 11,4, and IFN--y or a newly defined T cell cytokine,
Eta-1 (7, 11) (Fig . 1 B) . The Eta-1 gene encodes a secreted
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protein that binds specifically to macrophages, possibly via
a cell adhesion receptor, resulting in alterations in the mo-
bility and activation state of this cell type (7, 11) . In addi-
tion, recent studies have indicated that Eta-1 can enhance secre-
tion ofIgM andIgG by mixtures of macrophages andB cells
(Patarca, R ., M . A . Lampe, M . V Iregai, and H . Cantor,
manuscript in preparation) . TheDN variant Ar5v cells con-
stitutively expressed high levels of Eta-1 RNA and showed
a less pronounced but significant elevation in expression of
IFN- ,y RNA (Fig. 1 B) . Enhanced constitutive expression
of other TH1 cytokines, including 11,2 and IL3, was not
detected, nor was there evidence for aberrant expression of
the TI-12-associated rytokine, 11,4 (Fig. 1 B) .
Expression of Eta-1 by DN T Cells In Viva
￿
We asked
whether the expanded population of DN cells in peripheral
lymphoid tissues of MRLA mice also showed evidence of
dysregulated Eta-1 expression . Lymphadenopathy inMRL/1
mice secondary to expansion ofDN cells begins at ti3 mo
of age and reaches maximum levels by 5-6 mo of age (12) .
Elevated levels of Eta-1 RNA were detected in thymus, lymph
nodes (LN), and spleen from the MRL/1 mouse strain at 5 .5
mo ofage but not in lymphoid tissue of age-matched MRL/n
controls, which lack the lpr mutation and do not exhibit signs
of autoimmune disease at this time (Fig. 2) . The Eta-1 RNA
expressed by LN cells from MRL/l mice, and by Ar5v cells,
was indistinguishable from that found in activated T cells
from normal mice, as judged from Northern blot and S1
nuclease protection analysis (not shown) . We determined the
time course of elevated Eta-1 expression in the thymus and
LN of MRL/l and MRL/n mice to assess its relationship
to the development ofautoimmune disease. Eta-1 RNA levels
increased in thymus slightly before LN at 2.5-3 mo of age
and reached maximum levels by 4.5-5 mo of age (Fig. 3 A) .
In contrast, Eta-1 RNA levels were not significantly increased
inLN of control MRL/n mice during this time (Fig . 3 A) .
These kinetics o£enhanced Eta-1 expression paralleled the de-
velopment of overt autoimmune disease, which begins at
-3.5 mo of age and results in 50% mortality by 5-5.5 mo
of age (1, 12) .
The increase in Eta-1 expression compared with levels of
a housekeeping gene, GAPDH, over the period from 2.5 to
4.5 mo after birth, was -25-fold (Fig . 3 A) . However, the
absolute increase in Eta-1 expression in LN tissues was sub-
stantially higher because of the development of severe lymph-
adenopathy during this time : total levels of Eta-1 RNA in
peripheral LN ofMRL/I mice increased by N4 orders ofmag-
nitude (Fig . 3 B) .
CD1' DN cells comprise >90% of the cells ofLN from
MRL/l mice (2) and therefore were likely to account for the
bulk of elevated Eta-1 RNA levels . To define the contribu-
tion of this subset to enhanced Eta-1 expression, RNA was
extracted from separated DN cells and from CD4' or
CD8' T cells in LN . The DN population contained almost
all of the Eta-1 RNA expressed by unseparated lymph node
cells (Fig. 4) .
Comparison ofEta-1 Gene Expression to Expression ofOther
T Cell Cytokines . Analysis of the DN clone Ar5v indicated
high constitutive levels of Eta-1 expression and a modest butMean Fluorescence Intensity
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Figure 1 .
￿
(A) Surfacephenotypeofthe T cell clones
Ar5 and Ar5v. The CD4-8- surface phenotype of
Ar5v cells, but not the parent CD4'8 - Ar5 cells,
corresponds to that ofDN T cells that are abnormally
expanded in MRLA mice, including the expression
of the leukocyte common antigen (LCA) isoform
CD45R (B220) characteristic of B cells. Ar5v is a
variant clone that arose from thearsonate-reactive in-
ducer T cell clone Ar5 (4, 5) . The FRCS profiles ob-
tained for each antibody are shown and the intensity
of fluorescence is presented on a loglo scale. Back-
ground fluorescence profiles due to nonspecific binding
of the second antibody were obtained using PBS in-
stead of the relevant mAbs in the first incubation . (B)
Cytokine RNA expression for clones Ar5 and Ar5v.
Northern blot analysis showed that the probes used
for the Eta-1 gene hybridized to a single species of
RNA and that the size of the Eta-1 RNA transcript
in Ar5v cells was the same as that in Ar5 cells . Sl
nuclease protection analysis using the 5'-labeled 1 kb
BstXI-Sspl fragment from the Eta-1 cDNA insert in
pcD-Etal (7) confirmedthe identity ofboth transcripts
at the nucleotide sequence level (not shown) .
Figure 2.
￿
Eta-1 gene expression in lymphoid tissues
of MRL/l andMRL/n mice.
￿
Thymus, spleen, and
mesenteric LN were obtainedfrom 5-mo-oldMRLA
mice (which display marked lymphoid hyperplasia and
activated macrophages) and 6-mo-oldcongenic MRL/n
mice that had been housed in the same colony after
their arrival fromTheJackson Laboratory . 1, 3 .5, and
7 hg of total RNA were subjected to slot blot anal-
ysis using a 32P-labeled murine Eta-1 cDNA probe as
described in Materials and Methods.
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1 " O 1 10 1Figure 3. (A) Time course of Eta-1
RNA expression in LN and thymus cells
of MRL/l and MRL/n mice. Cellular
RNA was extracted from LN (") and
thymus (") from cohorts of MRLA and
MRL/n mice at the ages indicated on the
abscissa. The ratio ofEta-1RNA levels to
GAPDHlevels ofRNA from each cellular
sample, as measured by densitometric anal
ysis, is shown on the ordinate and expressed as relative densitometric units (RDU) (see Materials and Methods for details) . The points indicated in
the graph correspond to the mean of at least three different samples ; standard deviation of each mean value is <20% . The intensity of the autoradio-
graphic signals obtained after blotting RNA from heart, muscle, or adrenal gland with this Eta-1 cDNA probe did not exceed the background signal
of the film. (B) Total Eta-1 activity in LN from MRL/lmice. The levels of Eta-1RNA expressed as relative densitometric units (Eta-1/GAPDH) as
described forA are multiplied by the ratio of LN weight at the age indicated to LN weight at 1 mo of age. LN Eta-1 activity is depicted on a logto
scale. The hatched horizontal bar indicates the interval from the initial signs of autoimmune disease to the age corresponding to 50% mortality from
the disease process.
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significant elevation of IFN-y (Fig. 1) . We asked whether
this was also the case for the expanded population of DN
cells in the LN ofMRL/l mice, or whether these cells ex-
hibited amore generalized dysregulation of lymphokine gene
expression . We found that the levels of IL2, IL3, and IL4
RNA were not significantly elevated in MRL/l mice com-
pared with age-matched MRL/n controls, in contrast to the
striking -elevation of Eta-1 RNA levels (Fig. 5 ; Table 1) . As
was the case for theDN Ar5v clone, IFN-yRNA levels were
significantly elevated inLN fromMRL/1 mice . Increased ex-
pression of this cytokine was transient and was not evident
until relatively late in the disease process (4.5-5.5 mo) .
Moreover, the degree of elevation at this time was consider-
ably less than noted for Eta-1 (Fig. 5 ; Table 1) .
We studied expression ofEta-1 in nonlymphoid tissues of
MRL/l mice. Eta-1 was not significantly elevated in muscle,
heart or adrenal tissue (not shown) . However, substantial levels
ofEta-1 RNA were found in lung, consistent with the devel-
opment of peribronchial lymphocytic infiltration and pneu-
monitis associated with MRL/1 disease (1) . Analysis ofTCRa
levels in pulmonary tissue as a genetic marker of infiltrating
T cells showed that increased levels ofTCRa RNA cor-
related closely with elevation in Eta-1 expression in lung tissue
(Fig. 6) .
Genetic Control of Eta-1 Expression in MRL/1 Mice.
￿
The
above comparisons ofEta-1 RNA expression in MRLA and
Figure 4.
￿
Eta-1RNAlevels in
LN cells and in DN subpopula-
tions of T cells . RNA was ex-
tracted from either total lymph
node cell suspension or from the
adherent lg* (CD4*8+) and
nonadherent lg - (CD4- 8 -)
subpopulations obtained after pan-
ningLN cells with anti-CD4 and
anti-CD8 antibody as described
previously (24) . Immuno$uores
cent analysis of the separated subpopulations indicated that the nonad-
herent cells contained <1% CD4*, CD8+, or Ig* cells while contami-
nation of the CD4*8* cells with DN cells was 10-15% .
Eta-1 Expression in Murine Autoimmune Disease
MRL/n mice suggest that the lpr gene is necessary for elevated
expression of this gene in peripheral lymphoid cells. How-
ever, they did not distinguish between the following possi-
bilities: (a) the lpr gene is necessary and sufficient for elevated
Eta-1 expression or (b) the lpr gene and the associatedMRL
background gene(s) are both necessary for maximal expres-
sion of Eta-1 . The lpr mutation has been bred onto several
normal inbred strains, including C57BL/6J (B6/n) and
C3H/HeJ (C3H/n) (2) . This results in the development of
lymphadenopathy and formation of high levels of IgG au-
toantibodies. However, the C3H/l and B6/1 strains do not
develop the severe manifestations of autoimmune disease that
characterize MRL/l mice (2) . Comparison of Eta-1 RNA
levels in enlarged LN from B6/1, C3H/1, and MRL/l mice
showed that although the lpr gene was sufficient for eleva-
tion of Eta-1 RNA levels, MRL background genes (derived
from five inbred strains : C57BL/6J, C3H/HeJ, LG, AKR,
A/J) were required for maximal levels of expression (Fig. 7) .
The Ipr mutation is not likely to map to the Eta-1 locus since
its presence does not alter the restriction fragment length
polymorphic patterns of the Eta-1 gene in a panel of inbred
mouse strains (data not shown) .
Figure 5 .
￿
Comparison of in situ cytokine gene expression in MRLA
andMRL/n mice . The ratios of cytokine expression in MRL/landMRL/n
mice (RDU-MRLl / RDU-MRIrn) at 3.5 mo (/), 4.5 mo (§§), and
6.5 mo (0) are shown .RNA samples from LN ofMRLA and MRL/n were analyzed by slot blots, and levels of gene expression for each cytokine are expressed as relative
densitometric units (RDU) as described in Materials and Methods . Exposure times for autoradiograms were adjusted so that the intensity of the
autoradiographic signals associated with CAPDH was equivalent for MRLA and MRL/n RNA samples.
Discussion
The data presented in this report shed new light on the
role of abnormal T cell development in autoimmune disease
inMRLA mice. DN cells that are abnormally expanded in
thesemice constitutively express extremelyhigh levels ofEta-1
and thetime course ofenhanced expression is closely associated
with theonsetanddevelopmentofautcimmune disease . Eta-1
expression is also elevated in association with abnormal ex-
pansion ofDN cells in the C3H/l and B6/1 mouse strains.
However, increased Eta-1 expression in these two strains is
intermediate between normal inbred strains and the MRL/l
strain . This finding is consistent with the milder form of
autoimmune disease displayed by B6/1 and C3H/1, which
develop anti-DNA antibodies and rheumatoid factor but do
notdevelop severe immune complexglomerulonephritis (1, 2) .
Several explanations have been put forward to explain the
role of abnormal T cell differentiation in the development
of autoimmune disease in theMRLA model . One involves
a differentiative defect that results in failure to delete autoreac-
tiveT cell clones when they arise in the thymus. However,
several recent studies have failed to detect such abnormalities
(13, 14). A second holds that theDN subset constitutively
expresses elevated levels ofcytokines, resulting in chronic ac-
tivation of immunologic effector cells such as macrophages
andBcells (15) . Thestudiesreported here are consistent with
Figure 6.
￿
Expression ofEta-1
and TCR-a in lung tissue of
MRL/lmice. RNAwas extracted
from the lungs ofMRL/1mice at
the ages indicated in the figure and
subjected to slot blot analysis.
Levels ofEta-1 and TCR-aRNA
are expressed as relative densito-
metric units as described in
Materials and Methods.
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the latter explanation . DN cells that accumulate during this
disease do not divide rapidly in situ and by this criterion are
not in an activated state . However, DN cells may express an
alternative activation programmarked by elevated Eta-1 gene
expression as shown here, as well as constitutive phosphory-
lation ofCD3 (16) and expression ofthe proto-oncogene c-myb
(17) . The availability of the DN Ar5v cell line may allow
analysis in vitro of themolecular basis of this potential alter-
native activation pathway.
Elevated levels ofIFN-y in MRLA mice have been reported
previously, although thedegree of this elevation and its tem-
poral pattern were not determined (18, 19).We find that the
degree of elevation is relatively small compared with Eta-1
and occurs late and transiently in the course of disease. We
did not detect enhanced levels of 11,2, 11,3, or IIJ4 RNA,
which represent cytokines normally associated with T cell
inducer activity. Both Eta-1 andIFN-y can bind to and acti-
Figure 7.
￿
Maximum levels ofEta-1 inLN cells fromMRLA, C3H/1,
and B6/1 . Peripheral (axillary, brachial, femoral) and mesenteric lymph
nodes were obtained from the indicated mouse strains at 3-mo intervals .
Maximum levels of Eta-1 expression shown in the graph were observed
at 4.5 mo forMRLA mice, and at 7 mo for C3H/l and B6/1 mice. Cel-
lular RNA was extracted and analyzed as described in Materials and
Methods. The height of the bars corresponds to mean relative densito-
metric units. Standard errors were <20% of mean .
Table 1. Ontogeny of In Vivo Lymphokine/Cytokine Expression in MRL/1 and Congenic MRL/n mice
RNA expression at different months of age
ETA-1 IL-2 IL-3 IL-4 IFN-y
Mice Age : 3.5 4.5 6.5 3.5 4.5 6.5 3.5 4.5 6.5 3.5 4.5 6 .5 3.5 4.5 6.5
MRLA
MRL/n
_1.0
0.05
_4.7
0.23
_1 .9
0.15
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.23
RDU
0.3 1 .9
0.23 3.9
0.05
0.05
0.13
0.09
0.3
0.3
0.4
0.23
_1 .4
0.18
0.43
0.26vate macrophages (7, 11), consistent with evidence thatMRL/l
mice harbor activated macrophages that may mediate tissue
destruction (20) and indirectly contribute to enhanced Ig
production by B cells . Although the findings reported here
do not directly implicate Eta-1 in the pathogenesis of this
murine model of lupus, they indicate that elevated Eta-1 ex-
pression may represent a highly specific genetic marker for
theT cell developmental defect associated with this type of
autoimmune disease . Theappearance ofelevated levels ofEta-1
gene expression in the thymus before the appearance of sub-
stantial levels of DN T cells in the periphery and the dra-
matic and relatively selective increase of Eta-1 gene expres-
sion in DN T cells during the disease process suggest that
this cytokinemay also contribute to the pathogenesis of this
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